0001181431-14-034525.txt : 20141020
0001181431-14-034525.hdr.sgml : 20141020
20141020203059
ACCESSION NUMBER: 0001181431-14-034525
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141016
FILED AS OF DATE: 20141020
DATE AS OF CHANGE: 20141020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXACT SCIENCES CORP
CENTRAL INDEX KEY: 0001124140
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 204782291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
BUSINESS PHONE: 608-284-5700
MAIL ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
FORMER COMPANY:
FORMER CONFORMED NAME: EXACT CORP
DATE OF NAME CHANGE: 20000919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRAWFORD SALLY
CENTRAL INDEX KEY: 0001199735
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35092
FILM NUMBER: 141164776
MAIL ADDRESS:
STREET 1: C/O HOLOGIC, INC.
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
rrd417745.xml
OCTOBER 10B5-1 SALES
X0306
4
2014-10-16
0
0001124140
EXACT SCIENCES CORP
EXAS
0001199735
CRAWFORD SALLY
C/O EXACT SCIENCES CORP.
441 CHARMANY DRIVE
MADISON
WI
53719
1
0
0
0
Common Stock
2014-10-16
4
M
0
5000
2.24
A
217341
D
Common Stock
2014-10-16
4
M
0
15000
2.09
A
232341
D
Common Stock
2014-10-16
4
M
0
7768
3.00
A
240109
D
Common Stock
2014-10-16
4
S
0
27768
22.8418
D
212341
D
Common Stock
2014-10-17
4
M
0
7232
3.00
A
219573
D
Common Stock
2014-10-17
4
M
0
15000
0.71
A
234573
D
Common Stock
2014-10-17
4
M
0
5536
3.43
A
240109
D
Common Stock
2014-10-17
4
S
0
27768
23.6823
D
212341
D
Common Stock
2014-10-20
4
M
0
2131
3.43
A
214472
D
Common Stock
2014-10-20
4
M
0
15772
8.52
A
230244
D
Common Stock
2014-10-20
4
M
0
5257
8.52
A
235501
D
Common Stock
2014-10-20
4
M
0
4608
10.18
A
240109
D
Common Stock
2014-10-20
4
S
0
27768
23.9323
D
212341
D
Stock Option (right to buy)
2.24
2014-10-16
4
M
0
5000
0
D
2006-07-22
2015-07-22
Common Stock
15000
0
D
Stock Option (right to buy)
2.09
2014-10-16
4
M
0
15000
0
D
2007-07-21
2016-07-21
Common Stock
15000
0
D
Stock Option (right to buy)
3.00
2014-10-16
4
M
0
7768
0
D
2008-08-10
2017-08-10
Common Stock
15000
7232
D
Stock Option (right to buy)
3.00
2014-10-17
4
M
0
7232
0
D
2008-08-10
2017-08-10
Common Stock
7232
0
D
Stock Option (right to buy)
0.71
2014-10-17
4
M
0
15000
0
D
2009-07-18
2018-07-18
Common Stock
15000
0
D
Stock Option (right to buy)
3.43
2014-10-17
4
M
0
5536
0
D
2011-07-16
2020-07-16
Common Stock
7667
2131
D
Stock Option (right to buy
3.43
2014-10-20
4
M
0
2131
0
D
2011-07-16
2020-07-16
Common Stock
2131
0
D
Stock Option (right to buy)
8.52
2014-10-20
4
M
0
15772
0
D
2014-07-28
2021-07-28
Common Stock
15772
0
D
Stock Option (right to buy)
8.52
2014-10-20
4
M
0
5257
0
D
2012-07-28
2021-07-28
Common Stock
5257
0
D
Stock Option (right to buy)
10.18
2014-10-20
4
M
0
4608
0
D
2013-07-26
2022-07-26
Common Stock
4608
0
D
The exercise of these options and the subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted September 8, 2014. The sales of shares pursuant to this 10b5-1 trading plan and disclosed on this Form 4 reflect the execution of all shares subject to the 10b5-1 trading plan. As a result, the 10b5-1 trading plan has been terminated effective as of the filing of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.65 to $23.11, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.02, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.72 to $24.05, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
/s/ Sally Crawford by Mark R. Busch, attorney-in-fact
2014-10-20